Arrowhead Pharma Downgraded Following EX-1 RNAi Program Discontinuations
November 30, 2016 at 07:28 AM EST
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) announced it was discontinuing all its clinical RNAi programs. All these programs use ...
